S Traoré

Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance

Alain Morel, M. Boisdron‐Celle, Luc Fey et al. · Molecular Cancer Therapeutics · 2006 · 234 citations · Full text

5-Fluorouracil-related severe toxicity: A comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency

M. Boisdron‐Celle, Gaëlle Remaud, S Traoré et al. · Cancer Letters · 2006 · 219 citations

Pretherapeutic Detection, Pharmacology, Pathology +5

Predictive Factors of Oxaliplatin Neurotoxicity: The Involvement of the Oxalate Outcome Pathway

Laurence Gamelin, Olivier Capitain, Alain Morel et al. · Clinical Cancer Research · 2007 · 123 citations

Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US

Ralph P. Insinga, David J. Vanness, Josephine Feliciano et al. · Journal of Medical Economics · 2018 · 106 citations

Oncology, Medicine, Cancer Management +12

Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US

Ralph P. Insinga, David J. Vanness, Josephine Feliciano et al. · Current Medical Research and Opinion · 2019 · 85 citations